Drawing for Serial No. 79394721

USPTO serial 79394721

Serial No. 79394721

Reviewed by CopyMark Law Group

Reg. 7830548Status 700Registered
Filing date
Status date
Registration date
Jun 17, 2025
Examiner
VELTEN, MALLORY KATE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79394721?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frederick H. Colen

Frederick H. Colen The Webb Law Firm420 Ft. Duquesne Blvd., Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of rare neurological diseases and cancerACTIVE—
035Business intermediary services relating to the commercializing of goods, namely, negotiation of commercial transactions for third partiesACTIVE—
042Scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; biotechnology research, namely, biotechnology testing; scientific research relating to pharmaceuticals; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; services for assessing the safety of pharmaceuticals, namely, testing of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 14, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 14, 2026FIMPFINAL DISPOSITION PROCESSED—
Oct 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 24, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 2, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 2, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 25, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 17, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 17, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 29, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 29, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 23, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2024RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 24, 2024RFRRREFUSAL PROCESSED BY MPU—
Sep 22, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 21, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2024DOCKASSIGNED TO EXAMINER—
May 13, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance